129 related articles for article (PubMed ID: 6238445)
1. Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukemia.
Velasco F; Torres A; Andres P; Martinez F; Gomez P
Thromb Haemost; 1984 Aug; 52(1):81-4. PubMed ID: 6238445
[TBL] [Abstract][Full Text] [Related]
2. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
[TBL] [Abstract][Full Text] [Related]
3. Functional activities and concentrations of plasmin inhibitors in normal subjects and D.I.C. patients.
Velasco F; Torres A; Andres P; Duran MI
Thromb Haemost; 1982 Jun; 47(3):275-7. PubMed ID: 6180498
[TBL] [Abstract][Full Text] [Related]
4. Alpha-2 antiplasmin in acute nonlymphoblastic leukemia.
Cofrancesco E; Pogliani E; Salvatore M; Moreo G; Boschetti C; Cortellaro M
Acta Haematol; 1989; 81(3):122-5. PubMed ID: 2469277
[TBL] [Abstract][Full Text] [Related]
5. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
6. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
Fukuda C; Iijima K; Nakamura K
Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
[TBL] [Abstract][Full Text] [Related]
7. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
Okajima K
Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
[TBL] [Abstract][Full Text] [Related]
10. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia.
Velasco F; Torres A; Rojas R; Alvarez MA; Gomez P; Castillo D
Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455
[TBL] [Abstract][Full Text] [Related]
11. [Alpha 2-plasmin inhibitor plasmin complex in patients undergone surgery in femoral neck fracture].
Takahashi Y; Kihara K; Saitoh J; Murai Y; Mori M
Rinsho Byori; 1990 Feb; 38(2):208-12. PubMed ID: 2139477
[TBL] [Abstract][Full Text] [Related]
12. [Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
Chuecas F; Loredo E; Muñoz B; Alfaro J; Grebe G; Lira P
Rev Med Chil; 1991 Sep; 119(9):984-9. PubMed ID: 1845106
[TBL] [Abstract][Full Text] [Related]
13. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Hanano M; Takizawa S; Tatewaki W; Shibata A
Am J Hematol; 1988 Jul; 28(3):162-6. PubMed ID: 2457307
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
García Frade LJ; García Avello A
Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
[No Abstract] [Full Text] [Related]
15. [Alpha 2plasmin-inhibitor . plasmin complex (PIC)--useful diagnostic and prognostic parameter].
Taniguchi T; Matsuo T; Hishikawa R; Yamaguchi A; Akato S; Shibatouge M
Rinsho Byori; 1991 Jul; 39(7):714-9. PubMed ID: 1833570
[TBL] [Abstract][Full Text] [Related]
16. [Association of acute leukemia with disseminated intravascular coagulation in adults. Analysis of 14 cases].
Zuazu I; Canals C; Sempere A; Martín S; Brunet S; Puig J; Fontcuberta J; Grau E
Med Clin (Barc); 1989 Oct; 93(12):441-4. PubMed ID: 2607808
[TBL] [Abstract][Full Text] [Related]
17. Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.
Kahle LH; Avvisati G; Lamping RJ; Moretti T; Mandelli F; ten Cate JW
Scand J Clin Lab Invest Suppl; 1985; 178():75-80. PubMed ID: 2418490
[TBL] [Abstract][Full Text] [Related]
18. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
[No Abstract] [Full Text] [Related]
19. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
[TBL] [Abstract][Full Text] [Related]
20. [Blood coagulation factors and proteinase inhibitors in cytostatic therapy of acute leukemia].
Anders O; Nagel HR; Ernst B; Konrad H; Zgola M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):769-80. PubMed ID: 2465258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
